表 2.
Variables | Early miscarriage group (n=35) | Control group (n=87) | Z/t/χ2 | P |
WBC, white blood cell; HGB, hemoglobin; PLT, blood platelet; TG, triglycerides; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; T3, Serum total triiodothyronine; T4, serum total thyroxine; ANA, antinuclear antibody; AECA, anti-endothelial cell antibo-dy; SSA, Sjögren’ s syndrome antigen A; SSB, Sjögren’ s syndrome antigen B; dsDNA, double-stranded DNA; RNP, ribonucleoprotein; C3, complement 3; C4, complement 4; IgA, immunoglobulin A; IgG, immunoglobulin G; IgM, immunoglobulin M; N/A, not applicable. | ||||
WBC/(×109/L), x±s | 8.3 ± 4.5 | 8.9 ± 4.2 | 0.663 | 0.510 |
HGB/(g/L), x±s | 108.7 ± 24.2 | 110.3± 23.1 | 0.339 | 0.736 |
PLT/ (×109/L), x±s | 136.6 ± 89.3 | 171.3 ± 95.5 | 1.898 | 0.062 |
TG/(mmol/L),x±s | 2.7 ± 1.2 | 2.8 ± 1.9 | 0.384 | 0.702 |
HDL-C/(mmol/L), x±s | 1.6 ± 0.4 | 1.7 ± 0.5 | 1.383 | 0.171 |
LDL-C/(mmol/L), x±s | 3.1 ± 1.3 | 3.2 ± 1.0 | 0.211 | 0.834 |
T3/(μg/dL), x±s | 96.6 ± 48.4 | 121.0 ± 38.2 | 1.351 | 0.196 |
T4/(μg/dL), x±s | 8.6 ± 3.1 | 10.7 ± 3.7 | 1.582 | 0.128 |
ANA positive, n (%) | 2 (5.7) | 3 (3.4) | N/A | 0.624 |
AECA positive, n (%) | 12 (34.3) | 7 (8.0) | 13.070 | < 0.001 |
Anti-SSA antibody positive, n (%) | 3 (8.6) | 2 (2.3) | N/A | 0.142 |
Anti-SSB antibody positive, n (%) | 2 (5.7) | 0 (0) | N/A | 0.081 |
Anti-dsDNA antibody positive, n (%) | 0 (0) | 1 (1.1) | N/A | >0.999 |
Anti-U1-RNP antibody positive, n (%) | 1 (2.9) | 0 (0) | N/A | 0.287 |
Low C3, n (%) | 4 (11.4) | 8 (9.2) | N/A | 0.741 |
Low C4, n (%) | 7 (20.0) | 17 (19.5) | 0.003 | 0.954 |
Elevated IgA, n (%) | 0 (0) | 2 (2.3) | N/A | >0.999 |
Elevated IgG, n (%) | 6 (17.1) | 4 (4.6) | N/A | 0.032 |
Elevated IgM, n (%) | 1 (2.9) | 3 (3.4) | N/A | >0.999 |
D-dimer/(μg/L), M (P25,P75) | 412.5 (207.5, 791.0) | 588.0 (346.0, 1138.8) | -0.726 | 0.468 |